Literature DB >> 19457871

Left ventricular morphology influences mortality after the Norwood operation.

M A Walsh1, B W McCrindle, A Dipchand, C Manlhiot, E Hickey, C A Caldarone, G S Van Arsdell, S M Schwartz.   

Abstract

BACKGROUND: Within the spectrum of congenital heart disease referred to as hypoplastic left heart syndrome (HLHS), there is variation in the morphology and function of the left ventricle which could influence outcomes after stage I Norwood palliation.
OBJECTIVE: To determine if left ventricular (LV) morphology is associated with outcome after stage I Norwood palliation for HLHS.
METHODS: Echocardiograms were reviewed from 108 patients who had undergone Norwood palliation at our institution over the past 11 years. Total cardiac diameter, thickness of the interventricular septum (IVS), LV area and LV myocardial area were calculated. Competing risk analysis was performed for survival to a stage II operation and to determine potential predictors.
RESULTS: From the Norwood operation up to stage II operation, mortality was predicted by IVS thickness, while the absence of right ventricular (RV) dysfunction was predictive of survival to stage II operation. For the complete pathway, from Norwood to the Fontan operation, mortality was predicted by IVS, a lower RV fractional area change and the presence of significant tricuspid regurgitation. Cardiac transplantation during this period was predicted by a lower RV fractional area change (p = 0.02) and a larger LV area in diastole.
CONCLUSIONS: These results indicate that LV hypertrophy and decreased RV function adversely effect survival after the Norwood operation. They suggest that LV morphology, especially septal hypertrophy, can influence outcomes in HLHS and should be considered when evaluating treatment options.

Entities:  

Mesh:

Year:  2009        PMID: 19457871     DOI: 10.1136/hrt.2008.156612

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  10 in total

1.  Elevated Aortic Augmentation Index in Children Following Fontan Palliation: Evidence of Stiffer Arteries?

Authors:  Deepti P Bhat; Pooja Gupta; Sanjeev Aggarwal
Journal:  Pediatr Cardiol       Date:  2015-04-02       Impact factor: 1.655

2.  New mechanistic and therapeutic targets for pediatric heart failure: report from a National Heart, Lung, and Blood Institute working group.

Authors:  Kristin M Burns; Barry J Byrne; Bruce D Gelb; Bernhard Kühn; Leslie A Leinwand; Seema Mital; Gail D Pearson; Mark Rodefeld; Joseph W Rossano; Brian L Stauffer; Michael D Taylor; Jeffrey A Towbin; Andrew N Redington
Journal:  Circulation       Date:  2014-07-01       Impact factor: 29.690

3.  Systemic Ventricular Dysfunction Between Stage One and Stage Two Palliation.

Authors:  Thomas J Kulik; Lynn A Sleeper; Christina VanderPluym; Stephen P Sanders
Journal:  Pediatr Cardiol       Date:  2018-06-13       Impact factor: 1.655

Review 4.  Stem cell therapy for CHD: towards translation.

Authors:  Brody Wehman; Osama T Siddiqui; Rachana Mishra; Sudhish Sharma; Sunjay Kaushal
Journal:  Cardiol Young       Date:  2015-08       Impact factor: 1.093

5.  The Impact of the Left Ventricle on Right Ventricular Function and Clinical Outcomes in Infants with Single-Right Ventricle Anomalies up to 14 Months of Age.

Authors:  Meryl S Cohen; Nicholas Dagincourt; Victor Zak; Jeanne Marie Baffa; Peter Bartz; Andreea Dragulescu; Gul Dudlani; Heather Henderson; Catherine D Krawczeski; Wyman W Lai; Jami C Levine; Alan B Lewis; Rachel T McCandless; Richard G Ohye; Sonal T Owens; Steven M Schwartz; Timothy C Slesnick; Carolyn L Taylor; Peter C Frommelt
Journal:  J Am Soc Echocardiogr       Date:  2018-07-03       Impact factor: 5.251

Review 6.  Left ventricle after palliation of hypoplastic left heart syndrome: friend, fiend, or innocent bystander?

Authors:  Jeffrey H Shuhaiber; Frank A Pigula
Journal:  Pediatr Cardiol       Date:  2013-03-22       Impact factor: 1.655

7.  Negative Impact of the Left Ventricular Remnant Morphology on Systemic Right Ventricular Myocardial Deformation in Hypoplastic Left Heart Syndrome.

Authors:  Alan P Wang; Angela M Kelle; Meredith Hyun; Chelsea L Reece; Phillip M Young; Patrick W O'Leary; M Yasir Qureshi
Journal:  Pediatr Cardiol       Date:  2020-10-26       Impact factor: 1.655

8.  Impact of Left Ventricular Morphology on Adverse Outcomes Following Stage 1 Palliation for Hypoplastic Left Heart Syndrome: 20 Years of National Data From Sweden.

Authors:  Katrin Fricke; Mats Mellander; Katarina Hanséus; Phan-Kiet Tran; Mats Synnergren; Jens Johansson Ramgren; Annika Rydberg; Jan Sunnegårdh; Magnus Dalén; Gunnar Sjöberg; Constance G Weismann; Petru Liuba
Journal:  J Am Heart Assoc       Date:  2022-03-29       Impact factor: 6.106

9.  Evaluation of Right Ventricular Function and Myocardial Microstructure in Fetal Hypoplastic Left Heart Syndrome.

Authors:  Jing Ma; Yaping Yuan; Li Zhang; Shizhen Chen; Haiyan Cao; Liu Hong; Juanjuan Liu; Xiaoyan Song; Jiawei Shi; Yi Zhang; Li Cui; Xin Zhou; Mingxing Xie
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

10.  Myocardial Deformation in Fontan Patients Assessed by Cardiac Magnetic Resonance Feature Tracking: Correlation with Function, Clinical Course, and Biomarkers.

Authors:  Alessia Callegari; Simona Marcora; Barbara Burkhardt; Michael Voutat; Christian Johannes Kellenberger; Julia Geiger; Emanuela Regina Valsangiacomo Buechel
Journal:  Pediatr Cardiol       Date:  2021-07-27       Impact factor: 1.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.